Vetsys Pharmaceutical
The global veterinary injectable suspensions market is undergoing a radical shift toward long-acting, highly bioavailable formulations. As livestock production intensifies globally, the demand for stable, effective anti-infective suspensions—especially those containing Amoxicillin, Ceftiofur, and Penicillin—has reached unprecedented levels.
Current trends emphasize "Controlled Release" technology. Modern injectable suspensions manufacturers are focusing on micronization techniques to ensure needle-passability and uniform drug distribution, reducing animal stress and optimizing therapeutic outcomes in large-scale farming.
Trust is paramount. Our operations are governed by strict GMP compliance and international ISO standards. With decades of pharmaceutical expertise, we provide high-reliability products that meet the rigorous scrutiny of global veterinary health authorities.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare. By utilizing AI-assisted molecular modeling and advanced stability testing, we ensure every injectable suspension maintains optimal viscosity and efficacy across diverse climates.
Precision Mold Injection
Automated Welding Systems
Cleanroom Assembly Line
Final Product Packaging
Pharma-Grade Injection Molding
Bottle Blow Molding
Today's global buyers—ranging from large-scale agrotechnical firms in Brazil to pharmaceutical distributors in Southeast Asia—are seeking more than just a product. They are looking for supply chain resilience and technical support. The procurement landscape is shifting toward:
China has become the global hub for Active Pharmaceutical Ingredient (API) production. As a leading factory, Vetsys leverages this proximity to secure the highest quality raw materials at competitive costs. Our advantages include:
Integrated Supply Chain: From raw material synthesis to final sterile filling, our end-to-end control ensures purity and cost-efficiency.
Customized OEM/ODM: We offer tailored concentrations and packaging sizes to meet localized market regulations across the globe.
Rapid Lead Times: With 30 million RMB capital backing and high-throughput machinery, we meet large-scale global demands without delay.
Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys believes that excellence in product quality is essential to long-term growth and sustainability. As part of our long-term vision, we invest in green technologies and environmentally friendly practices to minimize the impact of our operations. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
In addition to our strong presence in the domestic market, Vetsys is actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets. Our future strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare.
Extrusion Molding Process
Sterile Processing Area
Advanced Drying Systems
Precision Assembly Unit
High-Speed Packing Station
Excellence in Veterinary Science